ServiceTitan, Inc. (TTAN)
NASDAQ: TTAN · Real-Time Price · USD
112.94
+1.17 (1.05%)
At close: Aug 6, 2025, 4:00 PM
114.80
+1.86 (1.65%)
After-hours: Aug 6, 2025, 5:27 PM EDT
Blueprint Medicines Stock Forecast
Stock Price Forecast
The 13 analysts that cover Blueprint Medicines stock have a consensus rating of "Buy" and an average price target of $124.31, which forecasts a 10.07% increase in the stock price over the next year. The lowest target is $100 and the highest is $150.
Price Target: $124.31 (+10.07%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Blueprint Medicines stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $125 → $150 | Buy | Reiterates | $125 → $150 | +32.81% | Jul 22, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $107 → $109 | Hold | Maintains | $107 → $109 | -3.49% | Jun 6, 2025 |
| Loop Capital | Loop Capital | Hold Maintains $90 → $100 | Hold | Maintains | $90 → $100 | -11.46% | Jun 6, 2025 |
| Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +23.96% | Jun 6, 2025 |
| Baird | Baird | Buy Maintains $106 → $124 | Buy | Maintains | $106 → $124 | +9.79% | Jun 4, 2025 |
Financial Forecast
Revenue This Year
935.61M
from 771.88M
Increased by 21.21%
Revenue Next Year
1.07B
from 935.61M
Increased by 13.94%
EPS This Year
0.61
from -8.53
EPS Next Year
0.77
from 0.61
Increased by 26.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 967.8M | 1.1B | 1.3B |
| Avg | 935.6M | 1.1B | 1.2B |
| Low | 896.5M | 1.0B | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 25.4% | 19.9% | 18.7% |
| Avg | 21.2% | 13.9% | 14.2% |
| Low | 16.1% | 7.7% | 8.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.74 | 1.04 | 1.13 |
| Avg | 0.61 | 0.77 | 1.05 |
| Low | 0.49 | 0.61 | 0.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 70.5% | 45.8% |
| Avg | - | 26.7% | 35.8% |
| Low | - | -0.3% | 25.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.